Insiders who reported open-market trades in the last 12 months at the companies Edward Morrow Atkinson III files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
Amit Sachdev - $28.38M in VRTX purchases and sales in the last 12 months
Reshma Kewalramani - $19.74M in VRTX purchases and sales in the last 12 months
Carmen Bozic - $11.31M in VRTX purchases and sales in the last 12 months
Edward Morrow Atkinson III is a corporate insider, tracked as EVP, Chief Technical Ops. Off. of VERTEX PHARMACEUTICALS INC / MA (VRTX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Edward Morrow Atkinson III last file a Form 4?
The most recent primary Form 4 on record is dated 26 February 2026, one of 7 filings going back to 2025.
Has Edward Morrow Atkinson III been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($3.60M) across all tracked filings.
Edward Morrow Atkinson III is EVP, Chief Technical Ops. Off. of VERTEX PHARMACEUTICALS INC / MA (VRTX). 7 SEC Form 4 filings on record going back to 2025, most recently on 26 February 2026. Most recent open-market trade: sold $325K of VRTX on 26 February 2026. Lifetime open-market sales: $3.60M.
Recent transactions
12
The latest 12 SEC Form 4 transactions reported by Edward Morrow Atkinson III.
InsiderAlpha's records for Edward Morrow Atkinson III go back to 2025: 7 primary Form 4 filings, an average of 3.5 per year. 9 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
